NeuroAid is marketed by Moleac, incorporated in Singapore. Moleac focuses on safety, quality and clinical data to bring new medicines from China to mainstream medicine internationally.

Click here to know more about Moleac >

Several studies in China have demonstrated the safety profile of NeuroAid.

In addition, Neuroaid has been available in China for nearly 5 years and no severe adverse reactions were reported by the Chinese Authorities Pharmacovigilance.

Important research on NeuroAid is and will be conducted within the CHIMES society.

CHIMES society is one-of-a-kind international partnership that represents an innovative academic collaboration with the objective to establish new stroke treatments.

CHIMES is a Singaporean non profit society founded by a group of Key Opinion Leaders in stroke, South-East Asia regional experts and clinicians interested to implement a research project on Traditional Chinese Medicine Efficacy on Stroke recovery.

Click here to know more about CHIMES >

Some patient experience a dry throat / thirst sensation over time and are encouraged to drink more water.

To report any pharmacovigilance issue, please contact us at +65 6478 9430 or contact@moleac.net.